Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid-enhanced ultrasound for SLN mapping in melanoma
NCT02968680Phase 1Terminated
- Sponsor
- University of Southern California
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label trial of sonazoid in cutaneous melanoma (CM), sponsored by University of Southern California. Primary endpoint: Percent of patients with SLN identified by sonazoid-US alone or both sonazoid-US and conventional methods at 1 year. Started Apr 2017; status: terminated.
02
Drugs
sonazoid
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT02968680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968680.